HBLVX
Price
$15.53
Change
+$0.11 (+0.71%)
Updated
Dec 3 closing price
Net Assets
11.75B
USBLX
Price
$30.25
Change
+$0.05 (+0.17%)
Updated
Dec 3 closing price
Net Assets
893.01M
Interact to see
Advertisement

HBLVX vs USBLX

Header iconHBLVX vs USBLX Comparison
Open Charts HBLVX vs USBLXBanner chart's image
Hartford Balanced Income R6
Price$15.53
Change+$0.11 (+0.71%)
VolumeN/A
Net Assets11.75B
Victory Growth and Tax Strategy
Price$30.25
Change+$0.05 (+0.17%)
VolumeN/A
Net Assets893.01M
HBLVX vs USBLX Comparison Chart in %
View a ticker or compare two or three
VS
HBLVX vs. USBLX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBLVX is a Hold and USBLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HBLVX has more cash in the bank: 11.8B vs. USBLX (893M). HBLVX pays higher dividends than USBLX: HBLVX (3.48) vs USBLX (1.76). HBLVX was incepted earlier than USBLX: HBLVX (11 years) vs USBLX (37 years). HBLVX (0.56) is less costly to investors than USBLX (0.50). HBLVX is a more actively managed with annual turnover of: 61.00 vs. USBLX (17.00). HBLVX has a lower initial minimum investment than USBLX: HBLVX (0) vs USBLX (3000). USBLX annual gain was more profitable for investors over the last year : 7.31 vs. HBLVX (3.03). USBLX return over 5 years is better than : 42.19 vs. HBLVX (14.48).
HBLVXUSBLXHBLVX / USBLX
Total Expense Ratio0.560.50112%
Annual Report Gross Expense Ratio0.560.50112%
Fund Existence11 years37 years-
Gain YTD10.20510.075101%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/A3000-
Net Assets11.8B893M1,321%
Annual Yield % from dividends3.481.76198%
Returns for 1 year3.037.3142%
Returns for 3 years16.0140.6139%
Returns for 5 years14.4842.1934%
Returns for 10 years49.9298.1651%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RSSS2.990.03
+1.18%
Research Solutions
PRTA10.360.09
+0.88%
Prothena Corp
HOLX74.83-0.01
-0.01%
Hologic
BHC6.91-0.15
-2.06%
Bausch Health Companies
GNPX2.71-0.14
-4.91%
Genprex Inc.